Abemaciclib

Verzenio for Breast Cancer (The good & BAD news) What you need to know!

Dr. Amy - Cancer Expert & Cancer Survivor

Age-stratified findings from the monarchE trial of abemaciclib in breast cancer

Expert Discusses Promise of Abemaciclib for Breast Cancer Treatment

Targeted Oncology

4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC

5-year monarchE results: abemaciclib + ET in high-risk EBC

Understanding Abemaciclib: A New CDK4/6 Inhibitor

CDK4/6 Inhibitors Breast Cancer Nemeses is the EBC Party Over for Real-World Dance-Off?

EP. 10 | My experience with Verzenio (Abemaciclib) // high risk stage 3 breast cancer

Dr. Ellis on Abemaciclib in HR-Positive Breast Cancer

#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study

European Society for Medical Oncology (ESMO)

NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer

#abemaciclib | Uses, Dosage, Side Effects & Mechanism | Verzenio

monarchE: adjuvant abemaciclib in HR+ breast cancer

Dr Mouabbi on the Use of Ribociclib vs Abemaciclib in HR+/HER2– Breast Cancer

Abemaciclib for HR-Positive Metastatic Breast Cancer

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared...

What are CDK 4/6 Inhibitors for Breast Cancer?

Yerbba – Breast Cancer

Unlocking the Power of Abemaciclib Medication: A Game-Changer in Cancer Treatment

Abemaciclib for HR+/HER2- advanced or metastatic breast cancer

monarchE: adjuvant abemaciclib + endocrine therapy in patients with HR+, HER2- high-risk eBC